Du, Y. et al. 2024. Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study . Dermatology Practical & Conceptual. 14, 1 (Jan. 2024), e2024026. DOI:https://doi.org/10.5826/dpc.1401a26.